196 related articles for article (PubMed ID: 31920930)
1. Amide Proton Transfer Weighted Imaging Shows Differences in Multiple Sclerosis Lesions and White Matter Hyperintensities of Presumed Vascular Origin.
Sartoretti E; Sartoretti T; Wyss M; Becker AS; Schwenk Á; van Smoorenburg L; Najafi A; Binkert C; Thoeny HC; Zhou J; Jiang S; Graf N; Czell D; Sartoretti-Schefer S; Reischauer C
Front Neurol; 2019; 10():1307. PubMed ID: 31920930
[No Abstract] [Full Text] [Related]
2. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
3. Amide Proton Transfer MRI Could Be Used to Evaluate the Pathophysiological Status of White Matter Hyperintensities.
Guo Z; Meng Z; Mu R; Qin X; Zhuang Z; Zheng W; Liu F; Zhu X
J Magn Reson Imaging; 2022 Jul; 56(1):301-309. PubMed ID: 34854519
[TBL] [Abstract][Full Text] [Related]
4. Altered amide proton transfer weighted and diffusion signals in patients with multiple sclerosis: correlation with neurofilament light chain and disease duration.
Huang J; Liang Y; Shan Y; Zhao C; Li Q; Shen Z; Dong H; Qi Z; Lu J
Front Neurosci; 2023; 17():1137176. PubMed ID: 37179547
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
[TBL] [Abstract][Full Text] [Related]
6. Amide Proton Transfer Contrast Distribution in Different Brain Regions in Young Healthy Subjects.
Sartoretti T; Sartoretti E; Wyss M; Schwenk Á; Najafi A; Binkert C; Reischauer C; Zhou J; Jiang S; Becker AS; Sartoretti-Schefer S
Front Neurosci; 2019; 13():520. PubMed ID: 31178687
[TBL] [Abstract][Full Text] [Related]
7. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
[TBL] [Abstract][Full Text] [Related]
9. Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis.
Su C; Jiang J; Liu C; Shi J; Li S; Chen X; Ao Q
Neuroradiology; 2021 May; 63(5):685-693. PubMed ID: 32997164
[TBL] [Abstract][Full Text] [Related]
10. Amide proton transfer-weighted magnetic resonance imaging of human brain aging at 3 Tesla.
Zhang Z; Zhang C; Yao J; Gao F; Gong T; Jiang S; Chen W; Zhou J; Wang G
Quant Imaging Med Surg; 2020 Mar; 10(3):727-742. PubMed ID: 32269932
[TBL] [Abstract][Full Text] [Related]
11. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
12. Amide Proton Transfer-Weighted MRI Might Help Distinguish Amnestic Mild Cognitive Impairment From a Normal Elderly Population.
Guo Z; Jiang Y; Qin X; Mu R; Meng Z; Zhuang Z; Liu F; Zhu X
Front Neurol; 2021; 12():707030. PubMed ID: 34712196
[No Abstract] [Full Text] [Related]
13. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
14. Amide Proton Transfer (APT) MR imaging and Magnetization Transfer (MT) MR imaging of pediatric brain development.
Zhang H; Kang H; Zhao X; Jiang S; Zhang Y; Zhou J; Peng Y
Eur Radiol; 2016 Oct; 26(10):3368-76. PubMed ID: 26762941
[TBL] [Abstract][Full Text] [Related]
15. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
Eur Radiol; 2024 Mar; ():. PubMed ID: 38491129
[TBL] [Abstract][Full Text] [Related]
16. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
[TBL] [Abstract][Full Text] [Related]
17. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
[TBL] [Abstract][Full Text] [Related]
18. Image quality assessment and feasibility of three-dimensional amide proton transfer-weighted imaging for hepatocellular carcinoma.
Qi X; Wang Q; Shen Z; Duan M; Liu X; Pan J; Fan X; Jia L; Wang Y; Du Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1778-1790. PubMed ID: 38415164
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
[TBL] [Abstract][Full Text] [Related]
20. Metric to quantify white matter damage on brain magnetic resonance images.
Valdés Hernández MDC; Chappell FM; Muñoz Maniega S; Dickie DA; Royle NA; Morris Z; Anblagan D; Sakka E; Armitage PA; Bastin ME; Deary IJ; Wardlaw JM
Neuroradiology; 2017 Oct; 59(10):951-962. PubMed ID: 28815362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
